-- 
Benchmark Stocks Erase Early Advance; Inmarsat, AstraZeneca, Man Decline

-- B y   W i l l   H a d f i e l d
-- 
2011-06-27T08:03:50Z

-- http://www.bloomberg.com/news/2011-06-27/benchmark-stocks-erase-early-advance-inmarsat-astrazeneca-man-decline.html
U.K. stocks erased gains before
Greek lawmakers meet to debate austerity measures that the
European Union has made a condition of providing further aid to
the indebted country.  Inmarsat Plc dropped 1.4 percent as Citigroup Inc.
downgraded its recommendation on the shares.  AstraZeneca Plc (AZN) 
retreated 1.3 percent as the company and Bristol-Myers Squibb
Co. said patients taking their experimental diabetes pill had
more breast and bladder cancers than people using a standard
drug.  The benchmark FTSE 100 Index declined 0.1 percent to
5,693.69 at 9:02 a.m. in  London . The FTSE All-Share Index also
dropped 0.1 percent, while Irelandâ€™s ISEQ Index climbed 0.1
percent.  To contact the editor responsible for this story:
Will Hadfield at 
 whadfield@bloomberg.net  